The ExploraMed venture studio provides medical-device startups with substantial internal seed capital, follow-on funding pathways, proprietary IP and patent support, managed clinical-trial infrastructure, expert engineering and regulatory guidance, and comprehensive reimbursement, marketing, and commercialization support, giving founders an end-to-end platform for developing and bringing clinically validated medical technologies to market.

We typically invest $5 million–$21 million+ in newly created medical-device ventures, with approximately 35%–50%+ equity in early-stage venture-creation structures. ExploraMed creates companies internally, contributes capital, IP, engineering, clinical, legal, and commercial expertise, and then brings in external investors and management as the company develops.

Never

Never

Cap table simplification by consolidating multiple small investors into a single shareholder, streamlined administration and organizational processes for managing micro-investments, reduced fundraising and shareholder-management complexity, and a more efficient ownership structure that can support future institutional fundraising.

Sometimes

Never

Never

Sometimes

Never

Never

Never

Never